Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
about
Strategies to optimize respiratory muscle function in ICU patientsMuscle wasting in animal models of severe illnessCellular and molecular mechanisms of muscle atrophyHyperglycemia-induced diaphragm weakness is mediated by oxidative stress.Critical diaphragm failure in sudden infant death syndrome.Inhibition of the ubiquitin-proteasome pathway does not protect against ventilator-induced accelerated proteolysis or atrophy in the diaphragmMuscle-specific calpastatin overexpression prevents diaphragm weakness in cecal ligation puncture-induced sepsis.The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.Exercise training prevents TNF-α induced loss of force in the diaphragm of miceRegulation of ubiquitin-proteasome and autophagy pathways after acute LPS and epoxomicin administration in mice.Diaphragm muscle fiber weakness and ubiquitin-proteasome activation in critically ill patientsLoss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness.Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.Calcium-dependent phospholipase A2 modulates infection-induced diaphragm dysfunction.The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation.Basic and translational research: from molecule, to mouse, to man.SIDS-CDF Hypothesis Revisited: Cause vs. Contributing Factors.Bortezomib inhibits C2C12 growth by inducing cell cycle arrest and apoptosis.Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasomeTherapeutic Approaches in Mitochondrial Dysfunction, Proteolysis, and Structural Alterations of Diaphragm and Gastrocnemius in Rats With Chronic Heart Failure.Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.Eicosapentaenoic acid preserves diaphragm force generation following endotoxin administration.Detrimental effect of the proteasome inhibitor, bortezomib in bacterial superantigen- and lipopolysaccharide-induced systemic inflammation.Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic mice.Hydrogen sulfide prevents diaphragm weakness in cecal ligation puncture-induced sepsis by preservation of mitochondrial function.Cancer cachexia-when proteasomal inhibition is not enough.Out-FOX(O)ing proteolysis in sepsis.Mycobacterium ulcerans infections cause progressive muscle atrophy and dysfunction, and mycolactone impairs satellite cell proliferation.In utero LPS exposure impairs preterm diaphragm contractility.Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.Exercise prevents impaired autophagy and proteostasis in a model of neurogenic myopathy
P2860
Q26752654-10104654-F11F-4183-854C-A2296248C561Q27000450-13248CCC-7A57-4B56-BFD3-4C3168D6925BQ27012762-108ABFEA-0578-4139-A12E-1EEFF2C39D7AQ33751226-03076964-E051-4CCC-BD16-8DD28355BD3BQ33790261-3A6C24DA-FC68-4F5D-B819-49D6597FB58BQ33897472-77D2F0AB-09BB-43A2-95A3-1795B36C22E7Q34353928-99301DBE-8F49-4C9F-813E-26CF2282139AQ34483183-E9ADD9AC-3DA0-42B8-9A9A-04E2C42D7AFDQ34542081-C399E95D-CFE0-4940-BFCF-A1E2AC0438E4Q35178582-01633FE3-3F39-4701-848F-81F164CB6BBCQ35672602-1BAFE20A-0F8B-42DD-BF17-1B517E016E31Q36454351-E17BE26F-E613-4FFB-8BCA-4FD7BDC5CEC4Q36893329-18A9ACA2-DF34-4CB4-A499-3C52880E9728Q36976588-6FBCA4FC-9443-4117-91D4-0A7B7DB57B1AQ37337616-B62207F4-56F4-40B3-9373-62EF3D6A0762Q37578972-FA2D354F-E2C8-461C-9072-19C91CF52300Q37587218-4FEDB279-8AAF-4864-85F5-4CEE54B0778BQ37677121-7F6F3705-0100-4401-80F1-48526FECA3E4Q38105829-E4B1C0D5-9A7F-4E6C-908D-93E0D07B07FDQ38946714-7889DEE0-7FD3-4EE5-852A-85F7BEB56571Q39016673-1F157347-74EB-4E4C-81CA-962674549115Q41129584-B1B76C38-7DF8-438D-9AC1-CBEA7111E689Q41278550-9781AF1E-F078-4EA9-A821-E50A451035EFQ41316270-3F8BCC23-7B9B-45D8-A3CF-71DE31F5F6E8Q41364237-8017547E-9253-4FAB-B71A-31B73004902BQ41852980-FBB0025E-8116-4336-924E-9F04423183D1Q43097884-BD78A334-07FC-41FF-A019-54BC8DF46D14Q46187233-58A75D20-9B91-4BD4-90A4-42A6F48A7504Q47996428-9EE6F14A-3434-42DD-9DAC-EED2D29C21FEQ51033534-1F86FF1A-8B05-4279-9204-3DEA46766E59Q58797796-3AAA305D-8A33-4315-89B6-C0E9245E067E
P2860
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
@en
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
@nl
type
label
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
@en
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
@nl
prefLabel
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
@en
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
@nl
P2093
P2860
P1476
Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
@en
P2093
G S Supinski
L A Callahan
P2860
P304
L994-L1001
P356
10.1152/AJPLUNG.90404.2008
P577
2009-04-17T00:00:00Z